Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Olanzapine 10mg powder for solution for injection vials |
| BNF code | 040201060AAANAN |
| Virtual Therapeutic Moiety | Olanzapine |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 9 Jun 2004 |
| Previous name | Olanzapine 10mg injection vials |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products Available |
| Non-availability status date | 10 May 2021 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Olanzapine |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 10.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | solutioninjection.intramuscular |
| Dose Form | |
| Formulation | Powder for solution for injection |
| Drug Route | |
| Route | Intramuscular |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Xyquila 10mg powder for solution for injection vials (Eramol (UK) Ltd) | |
| Zyprexa 10mg powder for solution for injection vials (Parapharm Development Ltd) | |
| Virtual Medicinal Product Packs | |
| Olanzapine 10mg powder for solution for injection vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.